Royce Laboratories Inc. lost its bid to persuade the Supreme Court to give quick consideration to the generic drug industry's multibillion dollar fight over the right to market some drugs before the expiration of patents that were extended by an international trade treaty.
Royce loses bid for quick court hearing on gatt patent dispute.